Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow (Indirect Method) | ||||||||||
| Cash from operating activities | -45.93%365M | -25.84%858M | 16.03%1.88B | -28.33%4.44B | -42.60%675M | -22.04%1.16B | -21.22%1.62B | -32.96%6.19B | -26.68%1.47B | -37.28%1.18B |
| Net profit before non-cash adjustment | -42.32%533M | -17.83%719M | 17.31%1.57B | -18.39%4.11B | -19.86%924M | -27.39%875M | -9.34%1.34B | -39.40%5.04B | -34.01%1.21B | -41.68%1.15B |
| Total adjustment of non-cash items | -332.14%-390M | 198.94%93M | 50.17%446M | -57.33%332M | -2.33%168M | 23.58%-94M | -40.72%297M | 127.49%778M | 121.36%228M | 95.45%172M |
| -Depreciation and amortization | -47.32%59M | 20.18%131M | 17.00%117M | -8.46%433M | -5.88%112M | -6.84%109M | -15.25%100M | 1.28%473M | 0.00%119M | 0.00%119M |
| -Reversal of impairment losses recognized in profit and loss | --23M | ---- | ---- | --0 | --0 | --0 | --0 | --144M | --137M | --0 |
| -Share of associates | --26M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| -Disposal profit | 100.00%2M | -22.22%7M | 617.65%88M | -111.32%-6M | -50.00%1M | -65.38%9M | -342.86%-17M | 180.30%53M | 1,700.00%18M | 300.00%2M |
| -Remuneration paid in stock | -42.86%4M | -42.86%4M | 75.00%7M | 118.18%24M | 250.00%7M | 133.33%7M | 33.33%4M | -31.25%11M | -50.00%3M | -60.00%2M |
| -Other non-cash items | -1,150.00%-504M | -42.47%-312M | 11.43%234M | -222.68%-119M | -2.04%48M | 18.59%-219M | -42.62%210M | 229.33%97M | -113.04%-49M | 240.00%49M |
| Changes in working capital | 152.15%218M | -87.20%48M | -826.67%-139M | -102.70%-10M | -175.00%-418M | -6.72%375M | -118.99%-15M | -35.65%370M | -48.10%41M | 19.58%-152M |
| -Change in receivables | 1,106.33%1.59B | 26.59%338M | 522.58%193M | -180.82%-674M | -69.89%-158M | -57.95%267M | -95.35%31M | 42.81%834M | 6.27%-374M | -321.43%-93M |
| -Change in payables | -426.15%-1.37B | -378.70%-301M | -652.27%-331M | 243.53%666M | -333.33%-260M | 146.35%108M | 92.49%-44M | -5,055.56%-464M | -13.18%415M | 74.03%-60M |
| -Provision for loans, leases and other losses | ---4M | --11M | 50.00%-1M | ---2M | --0 | --0 | -100.00%-2M | --0 | --0 | --1M |
| Dividends paid (cash flow from operating activities) | ||||||||||
| Dividends received (cash flow from operating activities) | ||||||||||
| Interest paid (cash flow from operating activities) | ||||||||||
| Interest received (cash flow from operating activities) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax refund paid | 14.95%-643M | 0 | -140.27%-531M | 63.71%-977M | 41.35%-756M | 0 | 84.28%-221M | -9.34%-2.69B | 0 | -9.61%-1.29B |
| Other operating cash inflow (outflow) | 0 | 1M | 0.00%-1M | 0 | 200.00%1M | 0 | -1M | -1M | 0 | -200.00%-1M |
| Operating cash flow | -247.50%-278M | -25.76%859M | -3.57%1.35B | -1.09%3.46B | 29.82%-80M | -22.19%1.16B | 114.40%1.4B | -48.35%3.5B | -26.68%1.47B | -116.29%-114M |
| Investing cash flow | ||||||||||
| Net PPE purchase and sale | 60.00%-4M | 69.09%-17M | -100.00%-2M | -157.14%-90M | -100.00%-10M | -511.11%-55M | 90.91%-1M | -25.00%-35M | -1,100.00%-10M | 68.75%-5M |
| Net intangibles purchase and sale | 36.08%-62M | -29.33%-97M | -24.05%-98M | 11.03%-347M | -1.04%-97M | 16.67%-75M | 13.19%-79M | -23.81%-390M | -24.18%-113M | -20.00%-96M |
| Net business purchase and sale | --0 | --0 | ---196M | ---130M | --0 | ---- | ---- | --0 | ---- | ---- |
| Net investment product transactions | --0 | ---54M | ---365M | -1,750.00%-148M | --0 | ---- | ---- | 87.88%-8M | --0 | --0 |
| Advance cash and loans provided to other parties | --0 | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Dividends received (cash flow from investment activities) | --0 | ---- | ---- | -73.33%8M | --0 | ---- | ---- | -26.83%30M | --0 | --0 |
| Net changes in other investments | --0 | ---2M | ---1M | 0.00%-1M | --0 | ---- | ---- | -200.00%-1M | --0 | --0 |
| Investing cash flow | 38.32%-66M | 9.71%-307M | -727.50%-662M | -75.25%-708M | -5.94%-107M | -335.90%-340M | 21.57%-80M | -10.08%-404M | -38.20%-123M | -5.21%-101M |
| Financing cash flow | ||||||||||
| Net common stock issuance | --0 | ---- | ---- | -1,106,400.00%-11.06B | --0 | ---11B | --0 | -75.00%1M | --0 | --0 |
| Increase or decrease of lease financing | --0 | --0 | 0.00%-1M | 14.29%-6M | 0.00%-2M | 0.00%-2M | 0.00%-1M | 0.00%-7M | 0.00%-2M | 0.00%-2M |
| Cash dividends paid | 0.00%-538M | 0.00%-3M | 23.80%-685M | 17.18%-1.44B | 33.08%-538M | 25.00%-3M | 3.33%-899M | -1.34%-1.74B | -100.00%-2M | 8.53%-804M |
| Net other fund-raising expenses | ---- | ---- | ---- | -200.00%-1M | ---- | ---- | ---- | --1M | ---- | ---- |
| Financing cash flow | 0.37%-537M | 99.96%-4M | 23.78%-686M | -616.96%-12.51B | 33.13%-539M | -220,020.00%-11.01B | 3.33%-900M | -1.45%-1.75B | -50.00%-3M | 8.51%-806M |
| Net cash flow | ||||||||||
| Beginning cash position | 4.75%12.32B | -46.36%11.78B | -45.32%11.78B | 6.69%21.53B | -44.52%11.77B | 10.85%21.95B | 6.69%21.53B | 30.24%20.18B | 10.52%20.19B | 14.36%21.21B |
| Current changes in cash | -21.35%-881M | 105.38%548M | -99.52%2M | -822.81%-9.76B | 28.89%-726M | -825.71%-10.19B | 210.53%420M | -71.20%1.35B | -29.77%1.35B | -268.59%-1.02B |
| Cash adjustments other than cash changes | --0 | --0 | 50.00%-1M | ---1M | ---- | ---- | -100.00%-2M | ---- | ---- | ---- |
| End cash Position | 3.68%11.44B | 4.75%12.32B | -46.36%11.78B | -45.32%11.78B | -45.33%11.04B | -44.52%11.77B | 10.85%21.95B | 6.69%21.53B | 6.69%21.53B | 10.52%20.19B |
| Free cash flow | -83.96%-344M | -27.46%745M | -5.30%1.25B | -1.63%3.02B | 13.02%-187M | -26.01%1.03B | 139.56%1.32B | -52.20%3.07B | -29.65%1.35B | -135.60%-215M |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |